Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML

Ashley Leak Bryant; Kaitlyn Buhlinger

doi:10.6004/jadpro.2022.13.3.31

Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML

J Adv Pract Oncol. 2022 Apr;13(3):333-336. doi: 10.6004/jadpro.2022.13.3.31. Epub 2022 May 23.

Authors

Ashley Leak Bryant¹, Kaitlyn Buhlinger²

Affiliations

¹ UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, North Carolina.
² University of North Carolina Medical Center and University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina.

Abstract

Recent advances have resulted in an expansion of treatment options for AML, especially targeted therapies and low-intensity regimens. At JADPRO Live Virtual 2021, presenters reviewed novel and targeted oral chemotherapy for adults with AML and discussed multidisciplinary collaboration for patients with complex AML chemotherapy regimens.